NCT00040391 2016-12-01
A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer
Celgene Corporation
Phase 2 Terminated
Clinical Trials
6 trialsNCT00582426 2015-05-04
LARCID
Novartis
Phase 3 Completed
NCT01410955 2014-01-23
Prevention of Irinotecan Induced Diarrhea by Probiotics
Monsea Ltd.
Phase 3 Completed
NCT00006269 2012-05-25
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
Novartis
Phase 3 Terminated
NCT00050635 2009-11-19
STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
Novartis
Phase 4 Completed
NCT00036517 2005-06-24
Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer
PhytoCeutica
Phase 1/2 Terminated